ETS2 targets ZMYND11 to inhibit thyroid cancer progression via the mTOR signaling pathway. Shu T, Wu X, Wei C, Chen C, et al. PLoS One 2025;20:e0328881.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Shu T, Wu X, Wei C, Chen C, et al. ETS2 targets ZMYND11 to inhibit thyroid cancer progression via the mTOR signaling pathway. PLoS One 2025;20:e0328881.
PMID: 40938895